Seroprevalence against Diphtheria in Pregnant Women and Newborns in Colombia: New Arguments to Promote Maternal Immunization

The tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine is recommended during pregnancy for neonatal protection against pertussis, although little is known of the protection it provides against diphtheria. The work used a cross-sectional design to estimate seroprevalenc...

Full description

Bibliographic Details
Main Authors: Laura María Rivera-Santamaría, Doracelly Hincapié-Palacio, Jesús Ochoa, Felipe Vargas-Restrepo, Marta C. Ospina, Seti Buitrago-Giraldo
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/10/3/458
_version_ 1827624889556664320
author Laura María Rivera-Santamaría
Doracelly Hincapié-Palacio
Jesús Ochoa
Felipe Vargas-Restrepo
Marta C. Ospina
Seti Buitrago-Giraldo
author_facet Laura María Rivera-Santamaría
Doracelly Hincapié-Palacio
Jesús Ochoa
Felipe Vargas-Restrepo
Marta C. Ospina
Seti Buitrago-Giraldo
author_sort Laura María Rivera-Santamaría
collection DOAJ
description The tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine is recommended during pregnancy for neonatal protection against pertussis, although little is known of the protection it provides against diphtheria. The work used a cross-sectional design to estimate seroprevalence against diphtheria in 805 pregnant women with ≥37 gestation weeks and their newborns whose deliveries were attended in eight hospitals randomly chosen from a subregion of Antioquia, Colombia and to explore factors related with maternal protection. Levels of IgG antibodies were determined by using a commercial enzyme-linked immunosorbent assay test. Placental transfer of antibodies and crude and adjusted prevalence ratio (aPR) were analyzed to describe factors related with maternal protection against diphtheria. Protection against diphtheria was observed in 91.7% (95% CI 90.3–93.0) of the pregnant women and 93.1% (95% CI 91.7–94.4) of newborns, whose antibody levels were positively correlated (Spearman’s r = 0.769; <i>p</i> = 0.000). Maternal protection could be influenced by having been vaccinated during the current pregnancy (aPR 0.85, 95% CI: 0.82–0.93). The protective effect of vaccination during pregnancy and the efficiency of maternal antibody transfers were detected. Public health efforts should focus on increasing Tdap vaccination during each pregnancy to protect mothers and newborns against diphtheria.
first_indexed 2024-03-09T12:18:56Z
format Article
id doaj.art-86993c8deb144308badfc0412a140689
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-09T12:18:56Z
publishDate 2022-03-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-86993c8deb144308badfc0412a1406892023-11-30T22:43:13ZengMDPI AGVaccines2076-393X2022-03-0110345810.3390/vaccines10030458Seroprevalence against Diphtheria in Pregnant Women and Newborns in Colombia: New Arguments to Promote Maternal ImmunizationLaura María Rivera-Santamaría0Doracelly Hincapié-Palacio1Jesús Ochoa2Felipe Vargas-Restrepo3Marta C. Ospina4Seti Buitrago-Giraldo5“Hector Abad Gómez” National Faculty of Public Health, Universidad de Antioquia UdeA, Medellin 050010, Colombia“Hector Abad Gómez” National Faculty of Public Health, Universidad de Antioquia UdeA, Medellin 050010, Colombia“Hector Abad Gómez” National Faculty of Public Health, Universidad de Antioquia UdeA, Medellin 050010, Colombia“Hector Abad Gómez” National Faculty of Public Health, Universidad de Antioquia UdeA, Medellin 050010, ColombiaLaboratory of Public Health of the Regional Secretariat of Health and Social Protection of Antioquia, Medellin 050010, ColombiaLaboratory of Public Health of the Regional Secretariat of Health and Social Protection of Antioquia, Medellin 050010, ColombiaThe tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine is recommended during pregnancy for neonatal protection against pertussis, although little is known of the protection it provides against diphtheria. The work used a cross-sectional design to estimate seroprevalence against diphtheria in 805 pregnant women with ≥37 gestation weeks and their newborns whose deliveries were attended in eight hospitals randomly chosen from a subregion of Antioquia, Colombia and to explore factors related with maternal protection. Levels of IgG antibodies were determined by using a commercial enzyme-linked immunosorbent assay test. Placental transfer of antibodies and crude and adjusted prevalence ratio (aPR) were analyzed to describe factors related with maternal protection against diphtheria. Protection against diphtheria was observed in 91.7% (95% CI 90.3–93.0) of the pregnant women and 93.1% (95% CI 91.7–94.4) of newborns, whose antibody levels were positively correlated (Spearman’s r = 0.769; <i>p</i> = 0.000). Maternal protection could be influenced by having been vaccinated during the current pregnancy (aPR 0.85, 95% CI: 0.82–0.93). The protective effect of vaccination during pregnancy and the efficiency of maternal antibody transfers were detected. Public health efforts should focus on increasing Tdap vaccination during each pregnancy to protect mothers and newborns against diphtheria.https://www.mdpi.com/2076-393X/10/3/458seroepidemiological studiesdiphtheria-tetanus-acellular pertussis vaccinesimmunizationColombia
spellingShingle Laura María Rivera-Santamaría
Doracelly Hincapié-Palacio
Jesús Ochoa
Felipe Vargas-Restrepo
Marta C. Ospina
Seti Buitrago-Giraldo
Seroprevalence against Diphtheria in Pregnant Women and Newborns in Colombia: New Arguments to Promote Maternal Immunization
Vaccines
seroepidemiological studies
diphtheria-tetanus-acellular pertussis vaccines
immunization
Colombia
title Seroprevalence against Diphtheria in Pregnant Women and Newborns in Colombia: New Arguments to Promote Maternal Immunization
title_full Seroprevalence against Diphtheria in Pregnant Women and Newborns in Colombia: New Arguments to Promote Maternal Immunization
title_fullStr Seroprevalence against Diphtheria in Pregnant Women and Newborns in Colombia: New Arguments to Promote Maternal Immunization
title_full_unstemmed Seroprevalence against Diphtheria in Pregnant Women and Newborns in Colombia: New Arguments to Promote Maternal Immunization
title_short Seroprevalence against Diphtheria in Pregnant Women and Newborns in Colombia: New Arguments to Promote Maternal Immunization
title_sort seroprevalence against diphtheria in pregnant women and newborns in colombia new arguments to promote maternal immunization
topic seroepidemiological studies
diphtheria-tetanus-acellular pertussis vaccines
immunization
Colombia
url https://www.mdpi.com/2076-393X/10/3/458
work_keys_str_mv AT lauramariariverasantamaria seroprevalenceagainstdiphtheriainpregnantwomenandnewbornsincolombianewargumentstopromotematernalimmunization
AT doracellyhincapiepalacio seroprevalenceagainstdiphtheriainpregnantwomenandnewbornsincolombianewargumentstopromotematernalimmunization
AT jesusochoa seroprevalenceagainstdiphtheriainpregnantwomenandnewbornsincolombianewargumentstopromotematernalimmunization
AT felipevargasrestrepo seroprevalenceagainstdiphtheriainpregnantwomenandnewbornsincolombianewargumentstopromotematernalimmunization
AT martacospina seroprevalenceagainstdiphtheriainpregnantwomenandnewbornsincolombianewargumentstopromotematernalimmunization
AT setibuitragogiraldo seroprevalenceagainstdiphtheriainpregnantwomenandnewbornsincolombianewargumentstopromotematernalimmunization